InvestorsHub Logo
Followers 33
Posts 2842
Boards Moderated 2
Alias Born 10/24/2015

Re: jondoeuk post# 41

Friday, 03/29/2024 8:01:11 PM

Friday, March 29, 2024 8:01:11 PM

Post# of 47
''The third patient for the INKmune™ AML program in UK and EU has been enrolled and subsequent to their completion of follow-up, the company will wind down the AML program to focus resources on the prostate-cancer program and other solid tumors.'' https://www.globenewswire.com/news-release/2024/03/28/2854450/0/en/INmune-Bio-Inc-Announces-Year-End-2023-Results-and-Provides-a-Q4-Business-Update.html

Good luck to them in solid tumours!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INMB News